Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 GuidancePRNewsWire • 08/05/25
Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in NephrologyPRNewsWire • 07/31/25
Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease CarePRNewsWire • 07/31/25
Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferencePRNewsWire • 07/30/25
Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy DevelopmentPRNewsWire • 05/13/25
Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and WebcastPRNewsWire • 04/24/25
UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research ExcellencePRNewsWire • 01/23/25
Azenta (AZTA) Surges 7.2%: Is This an Indication of Further Gains?Zacks Investment Research • 12/19/24
Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600PRNewsWire • 11/19/24
Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFOPRNewsWire • 11/12/24
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and WebcastPRNewsWire • 11/04/24